Aduro Biotech Announces Phase 2 Clinical Trial Results for Pancreatic Cancer ...

Aduro Biotech Announces Phase 2 Clinical Trial Results for Pancreatic Cancer ...
Patients were randomized in a 2:1 ratio to receive two doses of GVAX Pancreas vaccine followed by four doses of CRS-207 (Arm A) or to receive six doses of GVAX Pancreas vaccine alone (Arm B). The results were more pronounced in a pre-defined subset ...
Read more on Business Wire (press release)




Shortage for vaccine to cure 'radioactive boy'
Because of that, Ben was admitted into a trial for a vaccine that would prevent neuroblastoma from coming back. The Brewer Family was planning many trips back and forth from Denver to Memorial Sloan Kettering Cancer Center in New York City for the ...
Read more on 9NEWS.com




Ask the Doctor: Lung Cancer
Lung cancer accounts for more deaths than any other cancer in both men and women and accounts for 27 percent of all cancer deaths. Saint Mary's Center for Cancer is one of the first in Nevada to provide the Superdimension system as an option for ...
Read more on KTVN

0 Response to "Aduro Biotech Announces Phase 2 Clinical Trial Results for Pancreatic Cancer ..."

Post a Comment

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel